title: Digital vasculitis with eosinophilia possibly associated with etanercept therapy.
authors.affiliation: Department of Dermatology, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan.
authors.forename: Kyoko
authors.initials: K
authors.lastname: Nakahigashi
authors.forename: Gyohei
authors.initials: G
authors.lastname: Egawa
authors.forename: Yoshiki
authors.initials: Y
authors.lastname: Miyachi
authors.forename: Kenji
authors.initials: K
authors.lastname: Kabashima
mesh_terms: D000328:Adult; D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001706:Biopsy; D047150:Eosinophil Cationic Protein / Q000097:blood; D004802:Eosinophilia / Q000139:chemically induced*; D000068800:Etanercept; D005260:Female; D005385:Fingers / Q000098:blood supply* / Q000473:pathology; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage / Q000009:adverse effects*; D015848:Interleukin-5 / Q000097:blood; D018124:Receptors, Tumor Necrosis Factor / Q000008:administration & dosage; D012867:Skin / Q000473:pathology; D018366:Vasculitis, Leukocytoclastic, Cutaneous / Q000139:chemically induced* / Q000473:pathology
chemical_list: D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D015848:Interleukin-5; D018124:Receptors, Tumor Necrosis Factor; D047150:Eosinophil Cationic Protein; D000068800:Etanercept